Buys
Open market- Shares
- Avg price
- Total value
Coleen Glessner - EVP, Quality & Ethics, and CPL at Emergent BioSolutions Inc.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- EVP, Quality & Ethics, and CPL
- Issuer symbol
- EBS on NYSE
- Source filings
- Open source filing history
Identity
Issuer context
SEC evidence
Coleen Glessner - trading volume in the past year for Emergent BioSolutions Inc.
Sells
Open market- Shares
- -30,608
- Avg price
- $10.00
- Total value
- -$306,080
Net
Past year- Shares
- -30,608
- Share %
- -100%
- Total value
- -$306,080
Holdings reported by Coleen Glessner for Emergent BioSolutions Inc.
Form 4 holding
EVP, Quality & Ethics, and CPL
Emergent BioSolutions Inc.
- Security class
- Common Stock
- Shares / value
- 204,219
- Estimated value
- $1,695,017
- Report date
- 29 Apr 2026
- Price
- $8.30
- Ownership
- Direct
Form 4 holding
EVP, Quality & Ethics, and CPL
Emergent BioSolutions Inc.
- Security class
- Employee Stock Option (Right to buy)
- Shares / value
- 294,447
- Estimated value
- Report date
- 03 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP, Quality & Ethics, and CPL
Emergent BioSolutions Inc.
- Security class
- Employee Stock Options (Right to Buy)
- Shares / value
- 249,613
- Estimated value
- Report date
- 06 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Coleen Glessner for Emergent BioSolutions Inc.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.